HomeTCRX • NASDAQ
add
Tscan Therapeutics Inc
Previous close
$1.31
Day range
$1.23 - $1.33
Year range
$1.03 - $9.69
Market cap
70.17M USD
Avg Volume
424.19K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 2.17M | 283.57% |
Operating expense | 8.63M | 21.90% |
Net income | -34.13M | -13.22% |
Net profit margin | -1.57K | 70.48% |
Earnings per share | -0.26 | 18.75% |
EBITDA | -35.57M | -18.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 251.69M | 54.62% |
Total assets | 332.71M | 38.15% |
Total liabilities | 122.51M | 3.94% |
Total equity | 210.20M | — |
Shares outstanding | 56.59M | — |
Price to book | 0.35 | — |
Return on assets | -25.75% | — |
Return on capital | -28.07% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -34.13M | -13.22% |
Cash from operations | -37.59M | -28.42% |
Cash from investing | 13.53M | -62.59% |
Cash from financing | -525.00K | -303.49% |
Net change in cash | -24.58M | -443.60% |
Free cash flow | -27.60M | -42.97% |
About
Founded
2018
Headquarters
Website
Employees
201
